Antivirals Market Overall Study Report 2022-2031 | AbbVie Inc., Bristol-Myers-Squibb, Cipla, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc

The Antivirals Global Market Report 2021-31 by The Business Research Company describes and explains the global antivirals market and covers 2016 to 2021, termed the historic period, and 2022 to 2026, termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.

The Antivirals Global Market Report 2022 covers antivirals market drivers, antivirals market trends, antivirals market segments, antivirals market growth rate, antivirals market major players, and antivirals market size.

View Complete Report:

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

The antivirals market report provides in-depth analysis of the impact of COVID-19 on the global antivirals industry along with revised market numbers due to the effects of the coronavirus and the expected antivirals market growth numbers for 2022-2031.

The global antivirals market size is expected to grow from $85.08 billion in 2021 to $96.46 billion in 2022 at a compound annual growth rate (CAGR) of 13.4%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global anti-viral drug therapy market share is expected to reach $149.21 billion in 2026 at a CAGR of 11.5%.

Request Report Sample Now:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

Antivirals Global Market Report 2022 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.

TBRC’s report covers the antivirals market segments-

1) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others

2) By Application: HIV, Hepatitis, Herpes, Influenza, Others

3) By Type: Branded, Generic

Table Of Contents

1. Executive Summary

2. Anti-Viral Drug Therapy Market Characteristics

3. Anti-Viral Drug Therapy Market Trends And Strategies

4. Impact Of COVID-19 On Anti-Viral Drug Therapy

5. Anti-Viral Drug Therapy Market Size And Growth

…

27. Anti-Viral Drug Therapy Market Competitive Landscape And Company Profiles

28. Anti-Viral Drug Therapy Pipeline Analysis

29. Key Mergers And Acquisitions In The Anti-Viral Drug Therapy Market

30. Anti-Viral Drug Therapy Market Future Outlook and Potential Analysis

About The Business Research Company:

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.

Contact Information:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Find us on

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany/

Blog: http://blog.tbrc.info/